Patents Assigned to TERAIMMUNE, INC.
  • Patent number: 11597912
    Abstract: The present disclosure provides a method for producing a population of regulatory T cells comprising culturing an initial population of regulatory T cells obtained from umbilical cord blood in a media comprising an oligonucleotide having the sequence of AATCGTAACCGTCGTATCGGCGAT (SEQ ID NO: 1) to expand the initial population of regulatory T cells, and a method of treating an autoimmune disease comprising administering to a subject in need thereof an effective amount of a composition comprising the regulatory T cells prepared by the above method.
    Type: Grant
    Filed: March 31, 2022
    Date of Patent: March 7, 2023
    Assignee: TERAIMMUNE, INC.
    Inventors: Yong Chan Kim, Nari Byun, Jeong Heon Yoon
  • Publication number: 20220325243
    Abstract: The present disclosure provides a method for producing a population of regulatory T cells comprising culturing an initial population of regulatory T cells obtained from umbilical cord blood in a media comprising an oligonucleotide having the sequence of AATCGTAACCGTCGTATCGGCGAT (SEQ ID NO: 1) to expand the initial population of regulatory T cells, and a method of treating an autoimmune disease comprising administering to a subject in need thereof an effective amount of a composition comprising the regulatory T cells prepared by the above method.
    Type: Application
    Filed: March 31, 2022
    Publication date: October 13, 2022
    Applicant: TERAIMMUNE, INC.
    Inventors: Yong Chan KIM, Nari BYUN, Jeong Heon YOON